Member AUM
$70 trillion

Dechra Pharmaceuticals

LSE:DPH GB0009633180
Key Information
United Kingdom
Market Cap:
Primary Markets:
Europe & Russia, North America

Company Information

Company Summary

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. The company offers various companion animal veterinary products, as well as water-soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle. It markets its products through wholesaler and distributor networks, as well as through an in-house team of sales representatives, of which many are qualified veterinarians. In January 2024, the company was delisted from the London Stock Exchange and officially taken private.